Exact Sciences (EXAS) said Sunday it expects to report Q4 revenue of $713 million, up 10% from a year earlier.
Analysts polled by FactSet are expecting $696.9 million.
For full-year 2024, the company expects revenue to increase by 10% to $2.76 billion.
Analysts polled by FactSet are expecting $2.74 billion.
The company plans to report earnings in February.